Cyclo Therapeutics Inc.

NASDAQ: CYTH · Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM

Cyclo Therapeutics Revenue

Cyclo Therapeutics reported an annual revenue of $1.08M, reflecting a -21.76% growth. For the quarter ending September 30, 2024, Cyclo Therapeutics generated $233.77K in revenue.
Revenue (ttm)
1.08M
Revenue Growth
-21.76%
Price / Sales Ratio
24.12
Revenue / Employee
134.55K
Employees
8
Market Cap
23.59M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2023 1.08M -21.76%
Dec 31, 2022 1.38M -13.24%
Dec 31, 2021 1.59M +75.54%
Dec 31, 2020 903.38K -10.31%
Dec 31, 2019 1.01M -0.42%
Dec 31, 2018 1.01M -18.28%
Dec 31, 2017 1.24M -17.64%
Dec 31, 2016 1.5M +58.13%
Dec 31, 2015 950.46K -39.36%
Dec 31, 2014 1.57M -7.43%
Dec 31, 2013 1.69M +62.05%
Dec 31, 2012 1.04M +1.27%
Dec 31, 2011 1.03M +28.60%
Dec 31, 2010 802.37K +28.61%
Dec 31, 2009 623.87K +26.05%
Dec 31, 2008 494.94K -34.11%
Dec 31, 2007 751.18K +38.51%
Dec 31, 2006 542.31K +19.36%
Dec 31, 2005 454.36K -2.22%
Dec 31, 2004 464.69K +17.78%
Dec 31, 2003 394.53K -24.47%
Dec 31, 2002 522.37K +80.49%
Dec 31, 2001 289.43K -24.74%
Dec 31, 2000 384.59K n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.